Clinical Trial To Test Safety of Stem Cell-Derived Therapy for Type 1 Diabetes – UCSD Medical Center
|
Clinical Trial To Test Safety of Stem Cell-Derived Therapy for Type 1 Diabetes
UCSD Medical Center Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a … Research and Markets: Stem Cell Research Market in India 2014: How Stem … |
